Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasmintan A Schrader

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Clinical Obstetrics and Gynecology|October 10, 2017
The Role of Hereditary Factors in Ovarian CarcinomaKasmintan A Schrader
Surgical Pathology Clinics|June 1, 2016
Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?Gillian Mitchell, Kasmintan A Schrader
Archives of Pathology & Laboratory Medicine|August 31, 2016
How to Screen for Hereditary Cancers in General Pathology PracticeBrandon S Sheffield, Veronica Hirsch-Reinshagen, Kasmintan A Schrader
Oncogene|March 1, 2005
Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-RasXuecui Guo, Kasmintan A Schrader, Yaoxian Xu, et al.
Gut|September 8, 2020
Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposisKatherine Dixon, Janine Senz, Pardeep Kaurah, et al.
American Journal of Medical Genetics. Part A|June 27, 2007
Renal-hepatic-pancreatic dysplasia: an autosomal recessive condition that is not linked to the PKHD1 gene on chromosome 6p21.1-p12Kasmintan A Schrader, Tanya N Nelson, Deborah E McFadden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Cancer genomics and inherited riskZsofia K Stadler, Kasmintan A Schrader, Joseph Vijai, et al.
Frontiers in Bioscience (Elite Edition)|January 7, 2014
Clinical features and management of BRCA1 and BRCA2-associated prostate cancerShaheen R Alanee, Emily A Glogowski, Kasmintan A Schrader, et al.
Familial Cancer|October 23, 2012
Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrierShaheen Alanee, Sohela Shah, Rajmohan Murali, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 28, 2020
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communicationSamantha Pollard, Steve Kalloger, Deirdre Weymann, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Clinical Obstetrics and Gynecology|October 10, 2017
The Role of Hereditary Factors in Ovarian CarcinomaKasmintan A Schrader
Surgical Pathology Clinics|June 1, 2016
Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?Gillian Mitchell, Kasmintan A Schrader
Archives of Pathology & Laboratory Medicine|August 31, 2016
How to Screen for Hereditary Cancers in General Pathology PracticeBrandon S Sheffield, Veronica Hirsch-Reinshagen, Kasmintan A Schrader
Oncogene|March 1, 2005
Expression of a constitutively active mutant of M-Ras in normal bone marrow is sufficient for induction of a malignant mastocytosis/mast cell leukemia, distinct from the histiocytosis/monocytic leukemia induced by expression of activated H-RasXuecui Guo, Kasmintan A Schrader, Yaoxian Xu, et al.
Gut|September 8, 2020
Rare <i>APC</i> promoter 1B variants in gastric cancer kindreds unselected for fundic gland polyposisKatherine Dixon, Janine Senz, Pardeep Kaurah, et al.
American Journal of Medical Genetics. Part A|June 27, 2007
Renal-hepatic-pancreatic dysplasia: an autosomal recessive condition that is not linked to the PKHD1 gene on chromosome 6p21.1-p12Kasmintan A Schrader, Tanya N Nelson, Deborah E McFadden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Cancer genomics and inherited riskZsofia K Stadler, Kasmintan A Schrader, Joseph Vijai, et al.
Frontiers in Bioscience (Elite Edition)|January 7, 2014
Clinical features and management of BRCA1 and BRCA2-associated prostate cancerShaheen R Alanee, Emily A Glogowski, Kasmintan A Schrader, et al.
Familial Cancer|October 23, 2012
Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrierShaheen Alanee, Sohela Shah, Rajmohan Murali, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 28, 2020
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communicationSamantha Pollard, Steve Kalloger, Deirdre Weymann, et al.
Pageof 10